EPIGENESIS
DEAD

Serial Number

76113581

Owner

EPIGENESIS Pharmaceuticals, Inc.

Attorney

VIVIANA AMZEL

Filing Date

Aug 16, 2000

Add to watchlist:

No watchlists yet
View on USPTO

EPIGENESIS Trademark

Serial Number: 76113581

EPIGENESIS is a trademark filed by EPIGENESIS Pharmaceuticals, Inc. on August 16, 2000. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

EPIGENESIS Pharmaceuticals, Inc. (26 trademarks)

2055 East Park
Cranbury, NJ 08512

Entity Type: 03

Epigenesis Pharmaceuticals, LLC (13 trademarks)

2009 Eastpark Boulevard
Cranbury, NJ 08512

Entity Type: 16

Trademark Details

Filing Date

August 16, 2000

Registration Date

Not Registered

Published for Opposition

October 15, 2002

Goods & Services

Medical, diagnostic and therapeutic preparations and devices for administering same, sold filled, with diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 14, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 14, 2006 ABN6
SOU EXTENSION 5 GRANTED
Jul 1, 2005 EX5G
SOU EXTENSION 5 FILED
Jul 1, 2005 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 1, 2005 EEXT
SOU EXTENSION 4 GRANTED
Jan 10, 2005 EX4G
SOU EXTENSION 4 FILED
Dec 23, 2004 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 23, 2004 EEXT
SOU EXTENSION 3 GRANTED
Jul 30, 2004 EX3G
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 19, 2004 TCCA
PAPER RECEIVED
Jul 16, 2004 MAIL
CASE FILE IN TICRS
Jul 13, 2004 CFIT
SOU EXTENSION 3 FILED
Jul 6, 2004 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 6, 2004 EEXT
SOU EXTENSION 2 GRANTED
Jan 7, 2004 EX2G
SOU EXTENSION 2 FILED
Jan 7, 2004 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 7, 2004 EEXT
SOU EXTENSION 1 GRANTED
Jul 9, 2003 EX1G
SOU EXTENSION 1 FILED
Jul 3, 2003 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 3, 2003 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2003 NOAM
PUBLISHED FOR OPPOSITION
Oct 15, 2002 PUBO
NOTICE OF PUBLICATION
Sep 25, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2002 CNSA
SEC. 1(A) CLAIM DELETED
May 10, 2002 1.AD
Sec. 1(B) CLAIM ADDED
May 10, 2002 1.BA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2002 CRFA
FINAL REFUSAL MAILED
Nov 29, 2001 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2001 CRFA
NON-FINAL ACTION MAILED
Feb 12, 2001 CNRT